What is the Buying Price of Beryl Drugs Share?

The Buying Price of Beryl Drugs share is 20.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Beryl Drugs Share at Choice?

To buy Beryl Drugs stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Beryl Drugs, choose your preferred order type, and place the trade.

What is the PE ratio of Beryl Drugs Shares?

The Price-to-earnings (P/E) ratio of Beryl Drugs shares is 0. You can compare it with the sector average for relative valuation.

What is the PB ratio of Beryl Drugs Shares?

The Price to Book (P/B) ratio Beryl Drugs shares is 0. Useful to assess the stock's value relative to its book value.

Is Beryl Drugs Overvalued?

To assess Beryl Drugs’s valuation compare Sector P/E, P/B which are 71.7 & 3.51 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Beryl Drugs?

The Market Cap of Beryl Drugs is 10.19 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Beryl Drugs Share Price?

The 52 week high and low prices of Beryl Drugs share price is 30 & 15.92. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Beryl Drugs belong to?

Beryl Drugs belongs to the Healthcare sector.

Beryl Drugs Share price

BERLDRG

Healthcare Small Cap

20.1

0.00 (0.00%)

Last updated on 20 May, 2026 | 14:43 IST

BUYSELL

Today's High

20.15

Today's Low

20.10

52 Week Low

15.92

52 Week High

30.00

Free Demat with Zero AMC*

Beryl Drugs Chart

ChartIQ

TradingView

Beryl Drugs Share Key Metrics

Volume

681.00 Market Cap

10.19 CR

LTQ@LTP

100@20.10

ATP

20.1 Var Margin

32.22 %

Circuit Range

19.1-21.1

Delivery %

- %

Value

13688.10

ASM/GSM

No

Market Lot

1

Summary

20 May, 2026 | 14:43 को, Beryl Drugs का शेयर प्राइस आज ₹20.1 पर है, जो दिन के लिए 0.00% की 0.00 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹20.10 और ₹20.15 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹15.92 से ₹30.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Beryl Drugs ने 681 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹5071700 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹2010 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 100,2010 रही। यह स्टॉक ₹19.1-21.1 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹13688.10 है। दिन के लिए डिलीवरी परसेंटेज -1% रही। इसके अतिरिक्त, Beryl Drugs वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Beryl Drugs Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

71.7

Sector P/B

3.51

Sec. Div. Yield

0.56

Beryl Drugs Resistance and Support

Pivot 20.6

Resistance

First Resistance

21.1

Second Resistance

22.1

Third Resistance

22.6

Support

First Support

19.6

Second Support

19.1

Third Support

18.1

Beryl Drugs Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

26.38%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

73.62%

Others

0%

Total Promoters

MAR '24

26.38%

JUN '24

26.38%

SEP '24

26.38%

DEC '24

26.38%

Beryl Drugs Corporate Actions

Date	Agenda
2026-04-01	Notice of EGM & Others
2026-02-09	Quarterly Results
2026-01-03	Others

Beryl Drugs News

Beryl Drugs Ltd - 524606 - Board Meeting Intimation for Consider And Approve The Audited Financial Statement Including Balance Sheet, As At 31St March, 2026, Statement Of Profit And Loss, Cash Flow And Notes Thereon For The Year Ended 31St March, 2026.

Beryl Drugs' Board of Directors will convene on May 28, 2026, to consider and approve the audited financial statements for the year ended March 31, 2026. The agenda also includes the consideration and approval of related party transactions.

May 20 2026 21:05:00

Beryl Drugs Ltd - 524606 - PROCEEDINGS OF EGM

Beryl Drugs held an Extra-Ordinary General Meeting on May 11, 2026. Shareholders approved the regularization of Mr. Shailendra Pathak as Whole Time Director and the appointment of Mrs. Neha Sarda as a Non-executive Independent Director. A material related party transaction with M/S. Aminova Infusions P. Ltd. was also approved.

May 13 2026 17:05:00

Beryl Drugs Ltd - 524606 - ANNOUNCEMENT UBDER REGULATION 44 VOTING RESULTS OF EGM HELD ON 11TH MAY 2026

Beryl Drugs Limited shareholders, at the Extra-Ordinary General Meeting on May 11, 2026, unanimously approved three key resolutions. These include the regularization of a Whole Time Director, the appointment of a Non-Executive Independent Director, and a material related party transaction.

May 12 2026 17:05:00

Beryl Drugs Ltd - 524606 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Beryl Drugs held an Extra-Ordinary General Meeting on May 11, 2026, where shareholders unanimously approved all three proposed resolutions, including two director appointments and a material related party transaction.

May 12 2026 17:05:00

Beryl Drugs Ltd - 524606 - ANNOUNCEMENT UNDER REGULATION 30

Beryl Drugs' shareholders have approved a material related-party transaction (RPT) valued at Rs.5 crore with Aminova Infusions Pvt. Ltd. This 2-year agreement enables Aminova to distribute Beryl Drugs' products in new markets like Maharashtra and Gujarat, aiming to boost turnover and profits.

May 11 2026 17:05:00

Beryl Drugs Ltd - 524606 - Shareholder Meeting / Postal Ballot-Outcome of EGM

Beryl Drugs' Extra-Ordinary General Meeting (EGM) on May 11, 2026, approved the appointment of Mr. Shailendra Pathak as a whole-time director and Mrs. Neha Sarda as an independent director. Shareholders also approved material related party transactions with M/s. Aminova Infusions Pvt. Ltd.

May 11 2026 11:05:00

NSE : 0

BSE : 524606

ISIN : INE415H01017

Beryl Drugs Management

Name	Position
Sanjay Sethi	Managing Director
Sudhir Sethi	Chairman

Beryl Drugs Similar Stocks

Bacil Pharma Ltd.

54.60

2.36 (4.52%)

Ishita Drugs & Industries Ltd.

78.61

-0.39 (0.49%)

Emmessar Biotech & Nutrition Ltd.

25.40

-1.00 (3.79%)

Cian Healthcare Ltd.

8.26

0.00 (0.00%)

Sharma East India Hospitals & Medical Research Ltd

102.50

-0.50 (0.49%)

Clinitech Laboratory Ltd.

38.50

-1.00 (2.53%)

Starsource Multitrade Ltd.

115.00

-4.90 (4.09%)

Beryl Drugs FAQs

Beryl Drugs शेयर का खरीद मूल्य 20.1 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Beryl Drugs शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Beryl Drugs शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Beryl Drugs शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 0 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Beryl Drugs शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.51 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Beryl Drugs का मार्केट कैप 10.19 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Beryl Drugs शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 30.00 और 15.92 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।